Jennifer Tseng, MD, MPH
Emeritus Professor, Surgery
Biography
Dr. Tseng is a highly regarded surgical oncologist and gastrointestinal surgeon. She served as James Utley Professor and Chair of Surgery at the Boston University Chobanian & Avedisian School of Medicine and Surgeon-in-Chief at Boston Medical Center from 2017 until January 2024.
Dr. Tseng is a deputy editor of JAMA Surgery, a councilor on the American Board of Surgery, and past-President of the Society of Asian Academic Surgeons and of the Society for Surgery of the Alimentary Tract. She has published more than 150 peer-reviewed journal articles on reducing surgical risk, cancer biomarkers, and on developing models for cancer treatment sequencing strategies, with a strong focus on racial and socioeconomic disparities in care.
Dr. Tseng is also a dedicated educator of medical students and residents and has mentored numerous trainees throughout her career.
Websites
Education
- University of California, San Francisco, MD
- Harvard School of Public Health, MPH
- Stanford University, BS
Publications
- Published on 11/21/2024
Chang JH, Romatoski K, Torres MB, Sholevar CJ, Lindeman B, Gaskill C, Clark CN, Rocha F, Riall TS, Tseng JF, Davids JS, Pawlik TM, Walsh RM. GI Surgery Summit white paper: recruiting and training the next generation of surgeons. J Gastrointest Surg. 2025 Feb; 29(2):101896. PMID: 39580020.
Read at: PubMed - Published on 10/31/2024
Romatoski KS, Chung SH, Sawhney V, Papageorge MV, de Geus SWL, Ng SC, Kenzik K, Tseng JF, Sachs TE. Factors Associated With Surgical Management in Gallbladder Cancer-A Surveillance, Epidemiology, and End Results Medicare-Based Study. J Surg Res. 2024 Dec; 304:9-18. PMID: 39481161.
Read at: PubMed - Published on 9/14/2024
Shatsky RA, Trivedi MS, Yau C, Nanda R, Rugo HS, Davidian M, Tsiatis B, Wallace AM, Chien AJ, Stringer-Reasor E, Boughey JC, Omene C, Rozenblit M, Kalinsky K, Elias AD, Vaklavas C, Beckwith H, Williams N, Arora M, Nangia C, Roussos Torres ET, Thomas B, Albain KS, Clark AS, Falkson C, Hershman DL, Isaacs C, Thomas A, Tseng J, Sanford A, Yeung K, Boles S, Chen YY, Huppert L, Jahan N, Parker C, Giridhar K, Howard FM, Blackwood MM, Sanft T, Li W, Onishi N, Asare AL, Beineke P, Norwood P, Brown-Swigart L, Hirst GL, Matthews JB, Moore B, Symmans WF, Price E, Heditsian D, LeStage B, Perlmutter J, Pohlmann P, DeMichele A, Yee D, van 't Veer LJ, Hylton NM, Esserman LJ. Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial. Nat Med. 2024 Dec; 30(12):3737-3747. PMID: 39277672.
Read at: PubMed - Published on 8/13/2024
Switalla KM, Boughey JC, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait LM, Piltin M, Reyna CR, Matsen CB, Tuttle T, Wallace AM, Arciero CA, Lee MC, Tseng J, Son J, Rao R, Sauder C, Naik A, Howard-McNatt M, Lancaster R, Norwood P, Esserman LJ, Mukhtar RA. ASO Visual Abstract: Clipping the Positive Lymph Node in Patients with Clinically Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial. Ann Surg Oncol. 2024 Aug 13. PMID: 39138776.
Read at: PubMed - Published on 8/3/2024
Piltin MA, Norwood P, Ladores V, Mukhtar RA, Sauder CA, Golshan M, Tchou J, Rao R, Lee MC, Son J, Reyna C, Hewitt K, Kuerer H, Ahrendt G, Greenwalt I, Tseng J, Postlewait L, Howard-McNatt M, Jaskowiak N, Esserman LJ, Boughey JC. ASO Visual Abstract: Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy-Results from the I-SPY2 Clinical Trial. Ann Surg Oncol. 2024 Aug 03. PMID: 39097555.
Read at: PubMed - Published on 8/1/2024
Romatoski KS, de Geus SWL, Miriyam B, Chung SH, Kenzik K, Papageorge MV, Rasic G, Ng SC, Tseng JF, Sachs TE. ASO Visual Abstract: Overall Volume of Upper Gastrointestinal Surgery Positively Impacts Gastric Cancer Outcomes at Centers with Low Gastrectomy Volume. Ann Surg Oncol. 2024 Aug; 31(8):4952-4953. PMID: 38842677.
Read at: PubMed - Published on 7/12/2024
Switalla KM, Boughey JC, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait LM, Piltin M, Reyna CR, Matsen CB, Tuttle TM, Wallace AM, Arciero CA, Lee MC, Tseng J, Son J, Rao R, Sauder C, Naik A, Howard-McNatt M, Lancaster R, Norwood P, Esserman LJ, Mukhtar RA. Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial. Ann Surg Oncol. 2024 Oct; 31(11):7249-7259. PMID: 38995451.
Read at: PubMed - Published on 7/9/2024
Piltin MA, Norwood P, Ladores V, Mukhtar RA, Sauder CA, Golshan M, Tchou J, Rao R, Lee MC, Son J, Reyna C, Hewitt K, Kuerer H, Ahrendt G, Greenwalt I, Tseng J, Postlewait L, Howard-McNatt M, Jaskowiak N, Esserman LJ, Boughey JC. Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial. Ann Surg Oncol. 2024 Oct; 31(11):7420-7428. PMID: 38980586.
Read at: PubMed - Published on 7/3/2024
Beaulieu-Jones BR, Ha EJ, Fefferman A, Wang J, Chung SH, Tseng JF, Merrill A, Sachs TE, Ko NY, Cassidy MR. ASO Visual Abstract: Association of Race, Ethnicity, Language and Insurance and Time to Treatment Initiation Among Women with Breast Cancer at an Urban, Academic, Safety-Net Hospital. Ann Surg Oncol. 2024 Jul 03. PMID: 38961042.
Read at: PubMed - Published on 5/22/2024
Romatoski KS, de Geus SWL, Miriyam B, Chung SH, Kenzik K, Papageorge MV, Rasic G, Ng SC, Tseng JF, Sachs TE. Overall Volume of Upper Gastrointestinal Surgery Positively Impacts Gastric Cancer Outcomes at Centers with Low Gastrectomy Volume. Ann Surg Oncol. 2024 Aug; 31(8):5293-5303. PMID: 38777899.
Read at: PubMed
View 215 more publications: View full profile at BUMC